Basing on the data obtained on immunopathogenetic and lipid metabolism
features of intestinal yersiniosis and pseudotuberculosis in children
, the authors offer variants of etiotropic and pathogenetic treatment
specific for certain stages of the above diseases which are able to re
duce the rate of aggravations, recurrences and complications by 10-12%
. Long-term follow-up showed that unfavourable outcomes of yersinioses
are not infrequent this urging the necessity of 6-12-month follow-up
of the convalescents.